Expression of the ATM gene is significantly reduced in sporadic breast carcinomas

International Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 306-309

  Waha, Andreas ^a   Sturne, Chris ^a   Kessler, Astrid ^a   Koch, Anke ^a   Kreyer, Ellen ^a   Fimmers, Rolf ^a   Wiestler, Otmar D ^a   Von Deimling, Andreas ^a   Krebs, Dieter ^a   Schmutzler, Rita K ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; BREAST CARCINOMA; CANCER GROWTH; CANCER RISK; CHROMOSOME 11Q; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032578701     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981029)78:3<306::AID-IJC8>3.0.CO;2-Z     Document Type: Article

References (19)

1. AOUFOUCHI, S., YELAMOS, J. and MILSTEIN, C., Nonsense mutations inhibit RNA splicing in a cell-free system: recognition of mutant codon is independent of protein synthesis. Cell, 85, 415-422 (1996).
2. BASKARAN, R., WOOD, L.D., WHITAKER, L.L., CANMAN, C.E., MORGAN, S.E., Xu, Y., BARLOW, C., BALTIMORE, D., WYNSHAW-BORIS, A., KASTAN, M.B., and WANG, J.K.Y., Ataxia telangiectasia mutant protein activates c-Able tyrosine kinase in response to ionizing radiation. Nature (Lond.), 387, 516-519 (1997).
3. FITZGERALD, M.G., BEAN, J.M., HEDGE, S.R., UNSAL, H., MACDONALD, D.J., HARKIN, O.P., FINKELSTEIN, D.M., ISSELBACHER, K.J., and HABER, D.A. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature (Genet.), 15, 307-310 (1997).
4. GATTI, R.A., BODER, E., VINTERS, H.V., SPARKES, R.S., NORMAN, A. and LANGE, K. Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine, 70, 99-117 (1991).
5. GILAD, S., and 22 OTHERS, Predominance of null mutations in ataxia-telangiectasia. Hum. Mol. Genet., 5, 433-439 (1996).
6. KASTAN, M.B., ZHAN, O., EL-DEIRY, W.S., CARRIER, F., JACKS, T., WALSH, W.V., PLUNKETT, B.S., VOGELSTEIN, B. and FORNACE, A.J.J., A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in atexia-telangiectasia. Cell, 71, 587-597 (1992).
7. KERANGUEVEN, F., EISINGER, F., NOGUCHI, T., ALLIONE, F., WARGNIEZ, V., ENG, C., PADBERG, G., THEILLET. C., JACQUEMIER, J., LONGY, M., SOBOL, H. and BIRNBAUM, D., Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCAI gene regions. Oncogene, 14, 339-347 (1997).
8. KHANNA, K.K. and LAVIN, M.F., Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene, 8, 3307-3312 (1993).
9. LAKIN, N.D., WEBER, P., STANKOVIC, T., ROTTINGHAUS, S.T., TAYLOR, A.M. and JACKSON, S.P., Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene, 13, 2707-2716 (1996).
10. MEYN, M.S., Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res., 55, 5991-6001 (1995).
11. SAVITSKY, K. and 29 OTHERS, A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 268, 1749-1753 (1995a).
12. SAVITSKY, K., SFEZ, S., TAGLE, D.A., Ziv, Y., SARTIEL, A., COLLINS, F.S., SHILOH, Y. and ROTMAN, G., The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet., 4, 2025-2032 (1995).
13. SCHMUTZLER, R.K., FIMMERS, R., BIERHOFF, E., LOHMAR, B., HOMANN, A., SPEISER, P., KUBISTA, E., JEAGER, K., KREBS, D., ZEILLINGER, R., WIESTLER, O.D. and VON DEIMLING, A., Association of allelic losses on human chromosomal arms 11Q and 16Q in sporadic breast cancer. Int. J. Cancer, 69, 307-311 (1996).
14. SHAFMAN, T., KHANNA, K.K., KEDAR, P., SPRING, K., KOZLOV, S., YEN, T., HOBSON, K., GATEI, M., ZHANG, N., WATTERS, D., EGERTON, M., SHILOH, Y., KHARBANDA, S., KUFE, D. and LAVJN, M.F., Interaction between ATM protein and c-Abl in response to DNA damage. Nature (Lond.), 387, 520-523 (1997).
15. SWIFT, M., MORRELL, D., MASSEY, R.B. and CHASE, C.L., Incidence of cancer in 161 families affected by ataxia-telangiectasia. N. Engl. J. Med., 325, 1831-1836 (1991).
16. VORECHOVSKY, I., LUO, L., DYER, M.J., CATOVSKY, D., AMLOT, P.L., YAXLEY, J.C., FORONI, L., HAMMARSTROM, L., WEBER, A.D. and YUILLE, M.A., Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nature (Genet.), 17, 96-99 (1997).
17. VORECHOVSKY, I., RASIO, D., Luo, L., MONACO, C., HAMMARSTROM, L., WEBSTER, A.D., ZALOUDIK. J., BARBANTI-BRODANO, G., JAMES, M., Russo, G. and CROCE, C.M., The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res., 56, 2726-2732 (1996).
18. WAHA, A., WATZKA, M., KOCH. A., PIETSCH, T., PRZKORA, R., PETERS, N., WIESTLER, O.D. and VON DEIMLING. A., A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes. Brain Pathol., 8, 13-18 (1998).
19. WATZKA, M., WAHA, A., KOCH, A., SCHMUTZLER, R.K., BIDLINGMAIER, F., VON DEIMLING, A., KLINGMÜLLER, D. and STOFFEL-WAGNER, B., An optimized protocol for mRNA quantification using nested competitive RT-PCR. Biochem. Biophys. Res. Comm., 231, 813-817 (1997).